Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $90,215.73 -0.73%
Ethereum $3,108.16 +0.26%
BNB $892.94 -1.05%
Optimism $0.32 +2.14%
Arbitrum $0.21 +2.37%
Solana $133.25 -0.11%
Polygon $0.22 +2.77%
Cosmos $2.23 +1.56%
Avalanche $13.58 +0.43%

Bitcoin $90,215.73 -0.73%
Ethereum $3,108.16 +0.26%
BNB $892.94 -1.05%
Optimism $0.32 +2.14%
Arbitrum $0.21 +2.37%
Solana $133.25 -0.11%
Polygon $0.22 +2.77%
Cosmos $2.23 +1.56%
Avalanche $13.58 +0.43%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B